2 Biotech Stocks That Could Skyrocket In The Next 12 Months

By: via Benzinga
In separate reports published Monday, Piper Jaffray analyst Charles C. Duncan maintained an Overweight rating on both Threshold ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.